Manufacturing, Cell Therapies

Optima Teams Up with Clinics to Develop Production Unit for CAR-T Cell Therapies

June 16, 2021

Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.

CGT Catapult Forms Consortium to Accelerate Manufacturing Technology Development

June 11, 2021

The CGT Catapult has formed a consortium aimed at advancing the technology development and lowering costs of cell and gene therapy manufacturing.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

June 08, 2021

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

New Biotherapies Push Technological Innovation Forward

June 03, 2021

The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.

Thermo Fisher and UCSF Enter into Alliance to Accelerate Cell Therapy Development

May 20, 2021

Under the terms of the agreement, Thermo Fisher will construct and operate a 44,000-ft2 cell therapy development, manufacturing, and collaboration center on UCSF's Mission Bay campus.

Univercells and NIBRT Team Up to Address Needs for Cell and Gene Therapy Training

May 19, 2021

Univercells will introduce the intermediate capacity scale-X carbo system to NIBRT’s facility for hands-on demonstration and training in CGT.

Fujifilm Irvine Scientific Celebrates 50 Years of Providing Cell Culture Media Products and Services

May 12, 2021

Originally established in the 1970s as a fetal bovine serum supplier, Fujifilm Irvine Scientific continuously proved its strength in the cell culture solutions space.

Catalent to Acquire New Facility in Belgium for Commercial-Scale Plasmid DNA Manufacturing

May 06, 2021

Catalent has acquired Promethera Biosciences’ cell therapy manufacturing subsidiary, which includes a 32,400 ft2 facility in Gosselies, Belgium.

Cellares Raises Funding to Accelerate Cell Therapy Manufacturing Automation Device

May 05, 2021

Cellares has raised $82 million to accelerate the development of its Cell Shuttle, a factory-in-a-box that allows for the automation of the process of creating highly individualized cell therapies.

ViroCell Launched in the UK to Manufacture Viral Vectors

April 29, 2021

ViroCell will supply viral vectors and gene modified cells, to academic and corporate clients, for translational cell and gene therapies going into clinical trials.